SPONSOR

Second Affiliated Hospital, Zhejiang University, School of Medicine

Total Trials

Recruiting

Phases

Phase 2, Phase 1, Phase 2, Phase 4, Phase 1, Phase 3, EARLY_Phase 1

Conditions studied: Xerostomia Due to Radiotherapy (Disorder)Cholangiocarcinoma Immunoglobulin Light Amyloidosis Cardiomyopathy ST-elevation Myocardial Infarction (STEMI)Hepatocellular Carcinoma (HCC)Lens Diseases Idiopathic Normal Pressure Hydrocephalus Aphasia Dysarthria ALS

Second Affiliated Hospital, Zhejiang University, School of Medicine is a clinical research sponsor with 48 registered studies on ClinicalTrials.gov, of which 48 are actively recruiting participants. Research covers conditions including Xerostomia Due to Radiotherapy (Disorder), Cholangiocarcinoma, Immunoglobulin Light Amyloidosis Cardiomyopathy, ST-elevation Myocardial Infarction (STEMI).

The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Second Affiliated Hospital, Zhejiang University, School of Medicine

How many clinical trials has Second Affiliated Hospital, Zhejiang University, School of Medicine sponsored?

ClinicalMetric currently tracks 48 clinical trials sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine, of which 48 are actively recruiting participants. These trials cover conditions including Xerostomia Due to Radiotherapy (Disorder), Cholangiocarcinoma, Immunoglobulin Light Amyloidosis Cardiomyopathy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Second Affiliated Hospital, Zhejiang University, School of Medicine research focus on?

Second Affiliated Hospital, Zhejiang University, School of Medicine clinical trials span Xerostomia Due to Radiotherapy (Disorder), Cholangiocarcinoma, Immunoglobulin Light Amyloidosis Cardiomyopathy, ST-elevation Myocardial Infarction (STEMI), Hepatocellular Carcinoma (HCC), and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Second Affiliated Hospital, Zhejiang University, School of Medicine clinical trial?

To participate in a Second Affiliated Hospital, Zhejiang University, School of Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Second Affiliated Hospital, Zhejiang University, School of Medicine trials with current recruitment status updated daily.

Second Affiliated Hospital, Zhejiang University, School of Medicine

Frequently Asked Questions — Second Affiliated Hospital, Zhejiang University, School of Medicine

Clinical Trials by Second Affiliated Hospital, Zhejiang University, School of Medicine

Screening of Biomarkers and Related Mechanisms for RIX

Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

Clinical Study for AL-CM

Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction

A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC

Full 3D Eye Modeling in the Diagnosis and Treatment of Lens Diseases With Eye Structures Disorders

Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)

Chinese-Specific Speech Imagery Coding Using High-Density ECoG

A Point-of-care Electrochemical-based Device for Rapid Detection of Fibrinogen on Type A Aortic Dissection Surgery

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma

Safety and Efficacy of FAP iCDC in Ischemic Cardiomyopathy

Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer

Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer

Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction

SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement

Oriental Intervention for Enhanced Neurocognitive Health (ORIENT) Diet in Patients With Intracranial / Carotid Stenosis

Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC

Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma

Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma

Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression

ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse

Epidural Electrical Stimulation in Spinal Cord Injury

Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma

Comparison of Sequential to Initial Combination Therapy in PAH

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma

Conservative Treatment of Early Adhesive Capsulitis

Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder

Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab

Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules

B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma

A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients

Prospective Cohort Study of Intracerebral Hemorrhage

Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)

The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction

Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods

Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation

Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases

Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma

Clinical Evaluation of With or Without Internal Limiting Membrane Peeling for Idiopathic Epiretinal Membrane Surgery: A Randomized Controlled Trial

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)

Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC

The Osteoarticular Manifestations in Patients With Gitelman Syndrome

A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis